Kolexia
Denys Pierre
Médecine physique
Hôpital Raymond-Poincaré
Garches, France
235 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Vessie neurologique Traumatismes de la moelle épinière Vessie hyperactive Sclérose Incontinence urinaire Sclérose en plaques Infections urinaires Dysfonctionnement érectile Dysraphie spinale

Industries

Ipsen
8 collaboration(s)
Dernière en 2023
Coloplast
4 collaboration(s)
Dernière en 2023
Allergan
3 collaboration(s)
Dernière en 2021
Laboratoires Convatec
3 collaboration(s)
Dernière en 2023

Dernières activités

How to define failure of intradetrusor injections of botulinum toxin A for neurogenic detrusor overactivity.
Neurourology and urodynamics   07 mars 2024
Concomitant Botulinum Neurotoxin Injections for NDO and Spasticity – A Retrospective Analysis of Practice and Safety From a Referral Center
Toxins 2024 7th International Conference   01 janvier 2024
Évaluation à long terme des ballons ACT et Pro-ACT dans la prise en charge de l’incontinence urinaire d’effort
117e congrès français d'urologie   01 novembre 2023
MENOX: Efficacy of Intracavernosal (Xeomin®) 100U as add-on Therapy to Sildenafil 100 mg on Demand Compared to Sildenafil 100 mg on Demand for the Treatment of Erectile Dysfunction (ED) Not Sufficiently Responsive to Standard Therapy With Phosphodiesterase Type 5 Inhibitors
Essai Clinique (Assistance publique – Hôpitaux de Paris)   06 octobre 2023
INTRAVESICAL ADMINISTRATION OF EG110A, A NOVEL NON-REPLICATIVE HERPES SIMPLEX VIRUS TYPE 1 (HSV1)-DERIVED VECTOR EXPRESSING THE LIGHT CHAIN OF BOTULINUM TOXIN F, INHIBITS C-TYPE FIBERS IN AN ACUTE INTRAVESICAL CAPSAICIN RAT MODEL
ICS 2023 Toronto Abstracts   01 septembre 2023
Safety and Effectiveness of Repeated Botulinum Toxin A Intracavernosal Injections in Men with Erectile Dysfunction Unresponsive to Approved Pharmacological Treatments: Real-World Observational Data.
Toxins   05 juin 2023
Intravesical injections of botulinum neurotoxin A to treat overactive bladder and/or detrusor overactivity related to multiple sclerosis: 5-Year continuation rate and specific risk factors for discontinuation-A study from the neuro-urology committee of the French Association of Urology.
Multiple sclerosis (Houndmills, Basingstoke, England)   02 juin 2023
The International Continence Society (ICS) survey on intermittent catheterization and global practices with regard to the reuse of catheters
Continence (Amsterdam, Netherlands)   01 juin 2023
Autonomic Dysreflexia (AD): A serious, rather underestimated condition, a review based on Workshop 11, held on ICS Vienna 2022
Continence (Amsterdam, Netherlands)   19 avril 2023
Intracavernosal OnabotulinumtoxinA Exerts a Synergistic Pro-Erectile Effect When Combined with Sildenafil in Spontaneously Hypertensive Rats.
The journal of sexual medicine   17 avril 2023